Smith & Nephew PLC (NYSE:SNN) gapped up prior to trading on Thursday . The stock had previously closed at $33.24, but opened at $33.28. Smith & Nephew PLC shares last traded at $33.71, with a volume of 136,408 shares trading hands.

A number of equities research analysts recently issued reports on SNN shares. Jefferies Group raised shares of Smith & Nephew PLC from a “hold” rating to a “buy” rating in a research note on Monday, May 9th. Zacks Investment Research raised shares of Smith & Nephew PLC from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research note on Wednesday, April 13th. Barclays PLC cut shares of Smith & Nephew PLC from an “overweight” rating to an “equal weight” rating in a research note on Wednesday. Finally, Beaufort Securities reissued a “hold” rating on shares of Smith & Nephew PLC in a research note on Wednesday. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $37.00.

The stock has a market cap of $15.06 billion and a PE ratio of 42.44. The firm’s 50-day moving average is $33.94 and its 200 day moving average is $33.47.

A number of hedge funds and institutional investors have added to or reduced their stakes in the company. US Bancorp DE boosted its position in Smith & Nephew PLC by 37.6% in the fourth quarter. US Bancorp DE now owns 253,952 shares of the company’s stock valued at $9,041,000 after buying an additional 69,437 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Smith & Nephew PLC by 6.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 254,835 shares of the company’s stock valued at $9,072,000 after buying an additional 15,270 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its position in Smith & Nephew PLC by 4.3% in the fourth quarter. Wells Fargo & Company MN now owns 380,789 shares of the company’s stock valued at $13,556,000 after buying an additional 15,869 shares during the last quarter.

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.